Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mediterranean diet tested to ease endometriosis pain

NCT ID NCT07270393

Symptom relief Sponsor: Biogipuzkoa Health Research Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether following a Mediterranean diet can reduce inflammation and improve quality of life for women with endometriosis. Researchers will track pain, bloating, and fatigue in 104 women aged 18-45. The goal is to see if this anti-inflammatory diet helps manage symptoms better than usual care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mediterranean diet
What this could lead to
If it works, this could point toward a simple dietary approach to ease endometriosis symptoms and improve daily life.
What could go wrong
This is a small, early-stage study with no control group, so results may not be conclusive. Diet changes can be hard to stick with, and benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 104 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2025

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

INCLUSION CRITERIA: * Female. * Age 18-45. * Premenopausal status. * Radiological diagnosis (by transvaginal ultrasound and/or MRI) and/or surgical diagnosis of endometriosis. * Follow-up in the Gynecology Department of OSI Donostia (at least 1 visit in the last year). * Clinical score of at least 3/10 on the Numerical Scale in at least one symptom related to endometriosis). * Possibility of understanding Spanish. * Possibility of understanding the indicated dietary recommendations. * Acceptance of inclusion in clinical study, by signing informed consent. EXCLUSION CRITERIA: * Diagnosis of Eating Disorder. * Diagnosis of malabsorptive syndromes: Chron's disease, Ulcerative colitis, short bowel syndrome, gastric by-pass, irritable bowel. * Other concomitant diseases that produce CPD. * Autoimmune diseases.- * Metabolic diseases requiring follow-up of specific diets. * Diagnosed gluten intolerance. * Vegan diet. * Follow-up by a nutritionist. * Diagnosis of severe mental illness requiring treatment. * Pregnancy or current breastfeeding. * Active cancer process. * Personal history of gynecologic or digestive oncologic process. * Change of treatment or surgery during follow-up. * Surgery related to endometriosis or change of treatment in the 6 weeks prior to enrollment in the study. * Drug abuse. Opioid analgesia \< 3 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Endometriosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

endometriosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Endometriosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospital Universitario Donostia (HUD)

    Donostia / San Sebastian, Gipuzkoa, 20014, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.